2025 | The Association Between Location of BRCA Mutation and Efficacy of PARP Inhibitor as a Frontline Maintenance Therapy in Advanced Epithelial Ovarian Cancer
| CANCERS |
2024 | Mismatch repair, p53, and L1 cell adhesion molecule status influence the response to chemotherapy in advanced and recurrent endometrial cancer
| BMC CANCER |
2024 | Changes in the tumor immune microenvironment during disease progression in clear cell ovarian cancer | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2024 | Therapeutic effects of surgical debulking of metastatic lymph nodes in cervical cancer IIICr: a trial protocol for a phase III, multicenter, randomized controlled study (KGOG1047/DEBULK trial)
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
2024 | Unique immune characteristics and differential anti-PD-1-mediated reinvigoration potential of CD8 + TILs based on BRCA1/2 mutation status in epithelial ovarian cancers
| JOURNAL FOR IMMUNOTHERAPY OF CANCER |
2024 | RAD51 as an immunohistochemistry-based marker of poly(ADP-ribose) polymerase inhibitor resistance in ovarian cancer
| FRONTIERS IN ONCOLOGY |
2024 | The effectiveness of CA125 and HE4 as clinical prognostic markers in epithelial ovarian cancer patients with BRCA mutation
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
2024 | Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian Cancer | CANCER RESEARCH |
2024 | Development and validation of artificial intelligence-based analysis software to support screening system of cervical intraepithelial neoplasia
| SCIENTIFIC REPORTS |
2023 | Initial experience with the da Vinci SP robot-assisted surgical staging of endometrial cancer: a retrospective comparison with conventional laparotomy | JOURNAL OF ROBOTIC SURGERY |
2023 | Secondary cytoreductive surgery with and without hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer
| GLAND SURGERY |
2023 | Clinical relevance of sentinel lymph node biopsy in early ovarian cancer
| Obstetrics & Gynecology Science |
2023 | Comparison of progression-free survival outcome of sentinel node biopsy without ultrastaging versus lymphadenectomy in endometrial cancer: a propensity-matched analysis
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
2023 | Comparison of Single-Port Laparoscopy with Other Surgical Approaches in Endometrial Cancer Surgical Staging: Propensity-Score-Matched Analysis
| CANCERS |
2023 | Frequency of peripheral PD-1+regulatory T cells is associated with treatment responses to PARP inhibitor maintenance in patients with epithelial ovarian cancer | BRITISH JOURNAL OF CANCER |
2023 | Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4
| NATURE COMMUNICATIONS |
2023 | Clinical Relevance of Red Blood Cell Distribution Width (RDW) in Endometrial Cancer: A Retrospective Single-Center Experience from Korea
| CANCERS |
2023 | Comparison of oncological outcomes between sentinel lymph node biopsy and complete lymphadenectomy for endometrial cancer | JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH |
2023 | Investigation of PARP Inhibitor Resistance Based on Serially Collected Circulating Tumor DNA in Patients With BRCA-Mutated Ovarian Cancer | CLINICAL CANCER RESEARCH |
2023 | Comparing surgical outcomes of da Vinci SP and da Vinci Xi for endometrial cancer surgical staging in a propensity score-matched study
| SCIENTIFIC REPORTS |
2023 | Comprehensive genomic and immunohistochemical profiles and outcomes of immunotherapy in patients with recurrent or advanced cervical cancer
| FRONTIERS IN ONCOLOGY |
2023 | Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
2023 | HOXA‑AS3 induces tumor progression through the epithelial‑mesenchymal transition pathway in epithelial ovarian cancer
| ONCOLOGY REPORTS |
2023 | Clinical Relevance of Uterine Manipulation on Oncologic Outcome in Robot-Assisted versus Open Surgery in the Management of Endometrial Cancer | JOURNAL OF CLINICAL MEDICINE |
2022 | USEFULNESS OF PRE-OPERATIVE PET-CT IN PATIENTS WITH ENDOMETRIAL CANCER UNDERGOING SENTINEL LYMPH NODE MAPPING: DO NEGATIVE FINDINGS ON PET-CT NEGATIVITY REALLY INDICATE NODE NEGATIVITY? | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | THERAPEUTIC EFFECT OF SURGICAL DEBULKING OF METASTATIC LYMPH NODES IN CERVICAL CANCER STAGE IIICR: A PHASE III, RANDOMIZED CONTROLLED CLINICAL TRIAL (DEBULK TRIAL) | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | RE-VALIDATION OF CHEMOTHERAPY RESPONSE SCORE (CRS) AS A PROGNOSTIC FACTOR IN OVARIAN CANCER: THE EFFECT OF BEVACIZUMAB AND HIPEC ON SURVIVAL | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | RANDOMIZED COMPARISON BETWEEN SENTINEL LYMPH NODE MAPPING USING INDOCYANINE GREEN PLUS A FLUORESCENT CAMERA VERSUS LYMPH NODE DISSECTION IN CLINICAL STAGE I-II ENDOMETRIAL CANCER (KGOG2029/SELYE) | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | PROPENSITY SCORE-MATCHED COMPARISON OF PERIOPERATIVE OUTCOMES USING DA VINCI XI AND SP SURGICAL SYSTEM IN ENDOMETRIAL CANCER SURGICAL STAGING | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | PATIENT-DERIVED ORGANOIDS AS A PRECLINICAL PLATFORM FOR PRECISION MEDICINE IN PATIENTS WITH CERVICAL CANCER | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | IMMUNE PROPERTIES OF TUMOR-INFILTRATING LYMPHOCYTES IN OVARIAN CLEAR CELL CARCINOMA RELATIVE TO OVARIAN HIGH-GRADE SEROUS CARCINOMA | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR-2 (HER2) RECEPTOR EXPRESSION AND ITS DYNAMIC CHANGE IN OVARIAN CANCER PATIENTS | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | Expression profiles of id and E2A in ovarian cancer and sup-pression of ovarian cancer by the E2A isoform E47 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | Comprehensive profiling of cervix cancer patients using tumor next-generation sequencing (NGS) and immunohistochemistry (IHC) | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | Clinical relevance of red blood cell distribution as prognostic marker in endometrial carcinoma | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | Added value of sentinel lymph node biopsy in patients with negative lymph node on triple pre-operative images | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | Randomized comparison between sentinel lymph node mapping using indocyanine green plus a fluorescent camera versus lymph node dissection in clinical stage I-II endometrial cancer: a Korean Gynecologic Oncology Group trial (KGOG2029/SELYE)
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
2022 | Somatic genomic landscape of East Asian epithelial ovarian carcinoma and its clinical implications from prospective clinical sequencing: A Korean Gynecologic Oncology Group study (KGOG 3047) | INTERNATIONAL JOURNAL OF CANCER |
2022 | Response to letter to editor: indocyanine green fluorescent image-guided inguinal sentinel node biopsy for vulvar cancer: criteria and intraoperative challenges
| Obstetrics & Gynecology Science |
2022 | Usefulness and potential pitfalls of pre-operative PET-CT in patients with endometrial cancer undergoing one- and two-step sentinel lymph node mapping: Do negative findings on PET-CT negativity really indicate node negativity? | GYNECOLOGIC ONCOLOGY |
2022 | Feasibility and clinical applicability of genomic profiling based on cervical smear samples in patients with endometrial cancer
| FRONTIERS IN ONCOLOGY |
2022 | Interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in advanced-stage ovarian cancer: Single-institution cohort study
| FRONTIERS IN ONCOLOGY |
2022 | A Phase II Trial to Evaluate the Efficacy of Bortezomib and Liposomal Doxorubicin in Patients With BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer (KGOG 3044/EBLIN)
| IN VIVO |
2022 | A Pilot Study Testing the Efficacy of dCBT in Patients With Cancer Experiencing Sleep Problems
| FRONTIERS IN PSYCHOLOGY |
2022 | Expression Profiles of ID and E2A in Ovarian Cancer and Suppression of Ovarian Cancer by the E2A Isoform E47
| CANCERS |
2022 | Prognostic value of complete metabolic response on ¹⁸F-FDG-PET/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
2022 | Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer
| CANCERS |
2022 | Incidence of postoperative thrombotic events in ovarian cancer patients with a de-escalated prophylactic strategy: A retrospective cohort study | GYNECOLOGIC ONCOLOGY |
2022 | Indocyanine green fluorescent image-guided inguinal sentinel lymph node biopsy in vulvar cancer
| Obstetrics & Gynecology Science |
2022 | Da Vinci SP Single-Port Robotic Surgery in Gynecologic Tumors: Single Surgeon's Initial Experience with 100 Cases
| YONSEI MEDICAL JOURNAL |